Pharmacy Report Archives - Page 3 of 150 - Becker's Hospital Review

Providence names pharmacy chief | Henry Ford sues CVS over 340B losses | Trump proposes generic drug tariffs | HHS wins 340B rebate ruling | ASHP adopts 16 new pharmacy policies

Plus: GLP-1s cut long-term sick leave 17%: 4 study notes July 22, 2026 1. Providence names chief pharmacy officer Full story 2. Henry Ford Health sues CVS, alleges 340B pricing scheme Full story 3. Is your pharmacy losing margin to…

Pharmacist pay by state | UNC dismisses 340B underpayment lawsuits | Novo sues Lilly over GLP-1 ads | Iowa sanctions hospital pharmacy | GLP-1 compounders find FDA loophole

Plus: New Trump tariffs spare patented drugs: 3 things to know July 21, 2026 1. Pharmacist median pay by state Full story 2. UNC Health dismisses 340B underpayment lawsuits targeting Humana Full story 3. Prescription to pill takes 21 days.…

TrumpRx at 6 months: Has it worked? | Hidden costs of the GLP-1 boom | The drug pricing that could save Medicaid $8.6B | 9 pharmacy groups warn vaccine access at risk | Md. skipped audits on $675M in pharmacy claims

Plus: Conn. pauses plan to pursue lower-cost GLP-1s July 20, 2026 1. TrumpRx at 6 months: Has the drug-pricing experiment delivered? Full story 2. The hidden cost of the GLP-1 boom: 5 notes Full story 3. Becker’s 3rd Annual Fall…

Drug costs now hospitals' fastest-growing threat | AHA backs HHS in 340B fight | Half of new drug shortages tied to one manufacturer | FDA OKs pill to slash cholesterol | 10 systems hiring pharmacy leaders

Plus: CVS aims to lead Trump admin’s interoperability push July 16, 2026 1. Drug costs are becoming hospitals’ fastest-growing financial threat Full story 2. AHA backs HHS in AbbVie 340B court fight: 4 notes Full story 3. US drug spend hit…

CVS, FTC reach $13B insulin deal | Where pharmacy automation is delivering ROI | Children's hospitals' drug shortage playbook | Employer GLP-1 coverage holds at 36% | Alaska expands pharmacists' scope

Plus: How CHOP increased naloxone co-prescribing from 3% to 84% July 15, 2026 1. How children’s hospitals manage the nation’s most stubborn drug shortages Full story 2. CVS Caremark, FTC settle insulin pricing case for $13B Full story 3. Most…

340B hits record $100B + 10 most expensive drugs | 5 pharmacy leadership moves to know | FDA OKs 1st on-body cancer drug | Best US healthcare companies of '26: Time

Plus: Amazon Pharmacy brings real-time drug pricing to clinicians July 14, 2026 1. Top 10 340B drugs in 2025 Full story 2. 340B purchases reach record $100B: 5 things to know Full story 3. “We are out of time.” Learn…

How 8 systems are avoiding another chemo shortage | The next GLP-1 bet | Brand-name drug denials surge | CDC flips script on pharmacy deserts | 6 GLP-1 findings to know

Plus: 2.5M+ eye drop bottles recalled July 13, 2026 1. How 8 health systems are avoiding a repeat of the 2023 chemo shortage Full story 2. The next GLP-1 bet? Implant draws Novo interest Full story 3. The 340B Rebate…

The peptide boom explained | 3 drug recalls to watch | 5 drug spending numbers pharmacists should know | 10 systems hiring pharmacy leaders | Iowa reshapes medication abortion rules

Plus: Houston Methodist hospital names director of pharmacy July 9, 2026 1. The peptide boom: What healthcare leaders should know Full story 2. 3 drug recalls to know Full story 3. Learn how AI is helping pharmacy teams handle GLP-1…

Tampa General sues Lilly over 340B losses | 10 excellent hospital pharmacies: ASHP | 5K pharmacies accuse PBM of price fixing | Pharmacy's biggest legal fights: 4 updates | GLP-1 sites skip video visits: Study

Plus: 50 health systems with strong finances July 8, 2026 1. Tampa General sues Eli Lilly, alleges $24.7M in 340B losses Full story 2. 10 excellent hospital pharmacies: ASHP Full story 3. Showing medication costs at the point of care without…

Where pharmacy leaders are investing next | GLP-1 use hits record high: 6 notes | Judge blocks Colorado drug price cap | AHA seeks tariff exemptions for vital drugs | The $100M peptide gray market

Boston Children’s launches neurologic drug research program July 7, 2026 1. Where pharmacy leaders are investing next Full story 2. GLP-1 use hits record high in US as obesity rates fall: 6 things to know Full story 3. Ochsner cuts…